Abstract:Abstract Background Probiotic might have a role in the prevention of ventilator-associated pneumonia (VAP) among mechanically ventilated patients, but the efficacy and safety remained inconsistent. The aim of this systematic review and meta-analysis was to evaluate the efficacy and safety of probiotic (prebiotic, synbiotic) versus placebo in preventing VAP in critically ill patients undergoing mechanical ventilation. Methods PubMed, Embase and the Cochrane library databases were searched to 10 October 2021 without language restriction for randomized or semi-randomized controlled trials evaluating probiotic (prebiotic, synbiotic) vs. placebo in prevention of VAP in critically ill mechanically ventilated patients. The pooled relative risk (RR) along with 95% confidence intervals (CI) were combined using a random-effects model. Furthermore, the trial sequential analysis (TSA) and subgroup analyses were performed. Statistical significance was regarded as P < 0.05. Results Twenty-three trials involving 5543 patients were eligible for this meta-analysis. The combined RR of decreasing the risk of VAP by probiotic was 0.67 (0.56, 0.81) for all eligible studies, 0.69 (n = 5136; 95% CI = 0.57 to 0.84; P < 0.01) for adults studies and 0.55 (n = 407; 95%CI = 0.31 to 0.99; P = 0.046) for neonates/children studies. Additionally, the above-mentioned positive finding in 20 adults studies was verified by the results of TSA, subgroup analyses and cumulative meta-analysis. Ample evidences demonstrated a 31% decrease in RR of incidence of VAP was noted when prophylactic probiotic therapy was administrated among adult patients. Finally, there were no effects on the ICU/hospital/28-/90-day mortality, bacteremia, CRBSI, diarrhea, ICU-acquired infections, infectious complications, pneumonia, UTI and wound infection between two groups ( P > 0.05 for all). Conclusions Based on the results of our study, the current evidences suggested that prophylactic administration of probiotic might be utilized as a preventive method for VAP in neonates/children and adults patients who required mechanical ventilation. However, further large, high-quality RCTs are warranted to assess the efficacy and safety of probiotic treatment in critically ill patients, especially for the neonates/children studies and the long-term consequences of this therapy.

Probiotics For Preventing Ventilator-Associated Pneumonia: A Systematic Review And Meta-Analysis Of High-Quality Randomized Controlled Trials

Do Probiotics Help Prevent Ventilator-Associated Pneumonia In Critically Ill Patients? A Systematic Review With Meta-Analysis

Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials

Prevention of ventilator-associated pneumonia with probiotics: an overview of systematic reviews

Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial

Analysis of the risk factors and pathogenic bacteria of ventilator-associated pneumonia

The preventive effect of inhaled antibiotic against ventilator-associated pneumonia: a systematic review and meta-analysis

Probiotics effectiveness as an adjunct therapy in patients under mechanical ventilation: An umbrella systematic review and meta-analysis

Prophylactic Antibiotics Delivered Via the Respiratory Tract to Reduce Ventilator-Associated Pneumonia: A Systematic Review, Network Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials

Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis

Incidence and risk factors of ventilator-associated pneumonia in the intensive care unit: a systematic review and meta-analysis

[Comprehensive Prevention and Pathogenesis of Ventilator-Associated Pneumonia in Elderly Patients: a Prospective, Randomized, Case-Control Clinical Trial].

Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT

Role of bronchoscopy in the management of patients with suspected or suffering from ventilator-associated pneumonia: A meta-analysis

Efficacy of preventive interventions against ventilator-associated pneumonia in critically ill patients: An umbrella review of meta-analyses

Lower Respiratory Tract Microbial Composition Was Diversified in Pseudomonas Aeruginosa Ventilator-Associated Pneumonia Patients

Risk factors in patients with Acinetobacter baumanii ventilator-associated pneumonia

Risk Factors of Ventilator-Associated Pneumonia in Critically III Patients

Prevention and Treatment of Ventilator-associated Pneumonia:Their Characteristics